![DTB Podcast artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts123/v4/b7/ff/e6/b7ffe69d-a833-7d17-5986-c91912b9c87a/mza_4739691453721470086.png/100x100bb.jpg)
Overprescribing, overuse of short-acting beta agonists, inflammatory bowel disease in pregnancy
DTB Podcast
English - January 25, 2022 05:53 - 21 minutes - 49.5 MB - ★★★★★ - 4 ratingsScience Health & Fitness Medicine dtb drug and therapeutics bulletin therapy medical evidence Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the February 2022 issue of DTB. They talk about some of the details from a national report on overprescribing and discuss its implications (https://dtb.bmj.com/content/60/2/18). The editors review a study that highlighted overprescribing of short-acting beta agonists in people with asthma (https://dtb.bmj.com/content/60/2/21). They also discuss an article on prescribing for women of childbearing age who have inflammatory bowel disease and managing medicines during pregnancy (https://dtb.bmj.com/content/60/2/24).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.